Publication | Closed Access

Proliferation markers predictive of the pathological response and disease outcome of patients with breast carcinomas treated by anthracycline-based preoperative chemotherapy

Breast OncologyProliferation MarkersMedicinePathologyPathological ResponseBreast CancerBreast CarcinomasCancer TreatmentOncologyRadiation Oncology